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Background/aim: In the literature, there is a paucity of data about the effects of fibromyalgia syndrome (FMS) on myocardial function
and electrophysiological properties of atrium and ventricles. In this study, we investigated cardiac functions and noninvasive predictors
of arrhythmias in patients with FMS.
Materials and methods: The study included 43 female patients diagnosed with FMS and 30 age- and sex-matched healthy subjects.
The presence of fragmented QRS (fQRS) morphology, P dispersion, QT dispersion, inter- and intraatrial electromechanical delay was
evaluated in the groups with 12-lead ECG and standard and tissue Doppler echocardiography.
Results: Among electrocardiographic parameters, P dispersion, QT dispersion, and the ratio of presence of fQRS morphology were
found to be significantly higher in the study group as compared to the control group. In lateral and septal, the ratio of the early
transmitral flow velocity to the early diastolic tissue velocity (E/Em) was significantly higher in the study group. Additionally, intra- and
interatrial electromechanical delay was found significantly prolonged in the study group.
Conclusion: FMS is found to be associated with significant cardiac electrical alterations that may indicate the increased risk of atrial and
ventricular arrhythmias in this group of patients.
Key words: Arrhythmia, electromechanical delay, fragmented QRS, myocardial performance index, fibromyalgia syndrome

1. Introduction
Fibromyalgia syndrome (FMS) is a chronic painful disorder
of musculoskeletal system characterized by fatigue, sleep
disturbances, tenderness, and pain in the muscles [1]. Its
prevalence has been reported as 1–10% and usually seen
in middle-aged women [2]. Although many factors have
been implicated in the etiopathogenesis of the disease,
it has not been fully elucidated yet. Neuroendocrine
abnormalities including autonomic dysfunction were
thought to play an important role in the pathogenesis of
the disease [3,4]. Autonomic dysfunction characterized
by sympathetic hyperactivation and/or parasympathetic
dysfunction in FMS patients has been shown to be related
to many cardiovascular diseases including arrhythmias,
and suggested to be the cause of increased cardiovascular
mortality and morbidity [5–11].
Early detection of the risk in terms of arrhythmia
and cardiovascular disease in FMS patients is
important to decrease mortality and morbidity. Many
electrocardiographic and echocardiographic noninvasive
parameters have been studied to predict arrhythmias

likely to develop in various conditions. Among them,
P dispersion (Pd) and QT dispersion (QTd) obtained
from surface electrocardiography (ECG) have also been
investigated in FMS patients [12,13]. Another parameter,
atrial electromechanical delay (EMD) that has been defined
as the temporal delay between the onset of electrical
activity and the realization of force in the myocardium has
been widely studied to predict the risk of atrial fibrillation
in various diseases [14,15]. Recently, fragmented QRS
(fQRS) morphology, a new ECG parameter indicating
abnormality of ventricular depolarization, has also been
studied to predict atrial and/or ventricular arrhythmias
in several conditions [16,17]. In the literature, there is
a paucity of data about the effect of FMS on myocardial
function and electrophysiological properties of atrium and
ventricles. Thus, in this study, we evaluated electrical and
structural cardiac changes including Pd, QTd, atrial EMD,
fQRS, and myocardial performance index (MPI) by using
electrocardiography and transthoracic echocardiography
equipped with tissue doppler echocardiography (TDE) in
patients with FMS.
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2. Materials and methods
2.1. Patient selection
The study was designed as cross-sectional cohort study.
The patients applying to physical therapy and rehabilitation
clinic with the complaints of widespread musculoskeletal
pain, fatigue, and sleep disturbances and diagnosed with
FMS according to American College of Rheumatology
Criteria were assessed by Fibromyalgia Impact
Questionnaire (FIQ) and 43 female patients with scores of
≥50 were included in the study [18,19]. Age-matched 30
healthy women were taken as the control group. Patients
with history of hypertension, coronary artery disease, heart
failure, valvular heart disease, rhythm disturbances, bundle
branch blocks, electrolyte disturbances, collagen tissue
disease, morbid obesity, smoking, chronic alcohol use,
patients using medications affecting cardiac rhythm such
as antiarrhythmic, antipsychotic, and antihistaminic drugs,
and patients younger than 18 years old were not included in
the study. Demographic data (age, sex), body mass index
(BMI, kg/m2), arterial blood pressures, and heart rates of all
participants were recorded.
2.2. Laboratory investigation
Venous blood samples were taken from all participants after
12 h of fasting. Complete blood count including hemoglobin
level and leukocyte, neutrophil, and thrombocyte count
was measured from blood samples collected into tubes
with EDTA. Biochemical parameters including fasting
blood glucose, aspartate aminotransferase (AST), alanine
aminotransferase (ALT), total cholesterol, triglyceride,
low-density lipoprotein cholesterol (LDL-C), high density
lipoprotein cholesterol (HDL-C), C-reactive protein (CRP)
and thyroid stimulating hormone (TSH) were measured
from blood samples after centrifugation and serum
separation.
2.3. Electrocardiography
Standard 12- lead ECG samples were taken from all
participants at 25 mm/s velocity on a standard ECG paper

with 0.16–100 Hz filter range and 10 mm/mV voltage. Two
cardiologists who were blinded to patient data measured P
wave duration and QT interval from ECG samples by using
a 10-fold magnification lens. P wave duration (ms) was
measured from all derivations as the time between the onset
and the termination point of P wave. Pd was calculated as the
difference between maximum (Pmax) and minimum (Pmin)
P wave durations obtained from 12 derivations. QT interval
was measured from the beginning of the QRS complex to
the end of the T wave. QTd was defined as the difference
between the longest (QTmax) and the shortest (QTmin) QT
intervals obtained from 12 derivations. fQRS morphology
was defined as the presence of an additional R wave (R’), or
notching in the nadir of the R wave or the S wave in the
presence of normal QRS interval or the presence of > 1 R’
(fragmentation) in 2 contiguous leads corresponding to a
major coronary artery territory (Figures 1 and 2) [20].
2.4. Transthoracic echocardiography
Echocardiographic examination was performed from
left lateral decubitus position by using Vivid 7 (General
Electric, Horten, Norway, 2-4 MHz phased array
transducer) echocardiography machine. Echocardiographic
measurements were taken together with simultaneous ECG
recording by an experienced cardiologist as the average of
three cardiac cycles. The measurements of left atrium (LA),
aorta (Ao), left ventricular systolic (LVSD) and diastolic
(LVDD) diameters, diastolic thickness of interventricular
septum (IVSd) and posterior wall (PWd), left ventricular
ejection fraction (LVEF), and diameter of right ventricle
(RV) were obtained with M-mode echocardiography
from parasternal long axis view based on the guidelines of
American Society of Echocardiography. The areas of left and
right (RA) atriums were obtained from apical four chamber
view [21]. Mitral early diastolic (E), and late diastolic (A)
velocities were measured with PW Doppler during diastole
by placing sample volume to the tips of mitral leaflets,
and the ratio of the early (E) to late (A) ventricular filling
velocities (E/A) was calculated.

Figure 1. ECG sample demonstrating fragmentation of QRS in inferior derivations.
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Figure 2. ECG sample demonstrating fragmentation of QRS in
anterior derivations.

Tissue Doppler echocardiography (TDE) was
performed with transducer frequencies of 3.5–4.0 MHz
using a 5-mm pulsed Doppler sample volume. Spectral
Doppler signal filters were set to obtain a Nyquist limit
of 15 to 20 cm/s with minimal optimal gain settings. The
sweep speed was set at 50 to 100 mm/s. A single-lead
ECG was recorded simultaneously during measurements.
In the apical four chamber view, the sample volume
was subsequently placed at the level of LV lateral mitral
annulus, septal mitral annulus, and RV tricuspid annulus.
The sampling window was positioned as parallel as possible
to the myocardial segment of interest to obtain the optimal
angle of imaging. Peak systolic (Sm), early diastolic (Em),
late diastolic (Am) myocardial velocities, and isovolumic
contraction time (ICT; time interval between the end of Am
and the beginning of Sm), isovolumic relaxation time (IRT;
time interval between the end of Sm and the beginning
of Em), and ejection time (ET; time interval between the
beginning and the end of Sm) were obtained from mitral
and tricuspid annulus. The diastolic myocardial velocity
ratio (Em/Am) for both ventricle and the ratio of the
early transmitral flow velocity to the early diastolic tissue
velocity (E/Em) for left ventricle were calculated. The
myocardial performance index (MPI) was calculated using
the formula of (ICT + IRT) / ET for both ventricles. Time
intervals from the onset of P wave on the surface ECG
to the beginning of the A wave (PA) representing atrial
conduction were obtained from lateral mitral annulus,
septal mitral annulus, and tricuspid annulus and named

PA lateral, PA septum, and PA tricuspid, respectively.
The difference between PA lateral and PA tricuspid was
defined as interatrial EMD (PA lateral–PA tricuspid), the
difference between PA lateral and PA septum was defined
as intraatrial EMD (PA septum–PA tricuspid).
2.5. Assessment of functional status
FIQ was used to assess physical function and health status
of the patients with FMS. High scores indicate severe
involvement and low functionality level. Patients with
scores of ≥50 points were included in the study. Points
from 50 to 70 indicate moderate degree of involvement
while 70 points or more indicate severe involvement in
FMS patients [19].
2.6. Ethical approval
Informed consent was obtained from each patient
before enrollment. The study was in compliance with the
principles outlined in the Declaration of Helsinki and was
approved by our institutional ethics committee.
2.7. Statistical analysis
Data were analyzed with SPSS for Windows version 22
(SPSS Inc., Chicago, IL, United States). The Shapiro–
Wilk test was used to test the normality of distribution
for continuous variables. Continuous variables were
expressed as means ± standard deviation and median
(25% quartile–75% quartile). Categorical data were
presented as numbers and percentages. Difference
between groups was detected using chi-square test for
categorical variables. Mean values of continuous variables
were compared between groups using Student’s t-test or
the Mann–Whitney U-test according to whether normally
distributed or not. A P-value of <0.05 was considered
statistically significant.
3. Results
The study included 2 groups: the study group composed of
female patients with FMS (n = 43) and the control group
included healthy women (n = 30). Demographic data of
the two groups are given in Table 1. Systolic blood pressure
and resting heart rate of the patients in the study group
were significantly higher than those of the control group
(P < 0.05). There was no significant difference between
groups with regard to age, weight, height, body mass
index, and diastolic blood pressure.
Laboratory findings of the groups are shown in Table
2. Although being within the normal range, fasting blood
glucose, total cholesterol, triglyceride, LDL cholesterol,
ALT, leukocyte, neutrophil, and CRP were found to be
higher significantly in the study group as compared to
the control group (P < 0.05). HDL-C and TSH, in spite
of being within normal reference limits, were significantly
lower in the study group (P < 0.05).
Standard echocardiographic measurements of the
groups are given in Table 3. IVSd, PWd, areas of LA and
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Table 1. Demographic features of the groups.
Study group
(n=43)

Control group
(n=30)

P-value

Age (year)

36.16 ± 6.52

34.83 ± 5.56

0.366

FIQ score

63.91 ± 11.16

-

Weight (kg)

81.12 ± 9.99

78.10 ± 11.15

0.230

Height (m)

1.61 ± 0.07

1.62 ± 0.06

0.466

BMI (kg/m )

28.87 ± 3.73

27.17 ± 3.46

0.054

SBP (mmHg)

124.65 ± 10.54

116.67 ± 9.86

0.002*

DBP (mmHg) median (Q1-Q3)

75.00 (70.00-80.00)

70.00 (65.00–80.00)

0.104†

Heart rate (beat/m)

75.74 ± 10.28

71.20 ± 8.31

0.041*†

2

FIQ; Fibromyalgia impact questionnaire, BMI; Body mass index, SBP; Systolic blood pressure, DBP: Diastolic
blood pressure.
Independent samples t-test; †Mann–Whitney U-test; *Difference is statistically significant
Table 2. Laboratory findings of the groups.
Study group
(n = 43)

Control group
(n = 30)

P-value

FBG (mg/dL)

92.00 ± 9.95

87.00 ± 8.75

0.030*

Total cholesterol (mg/dL)

179.77 ± 43.28

160.20 ± 32.27

0.039*

Triglyceride (mg/dL) median (Q1-Q3)

140.00 (99.00–173)

86.00 (62.25–111.00)

<0.001*†

HDL-C (mg/dL) median (Q1-Q3)

42.00 (35.00–47.00)

57.50 (46.75–65.25)

<0.001*†

LDL-C (mg/dL)

123.37 ± 27.57

99.60 ± 34.01

0.002*

AST (UI/L)

18.04 ± 4.21

17.29 ± 2.95

0.747

ALT (UI/L) median (Q1-Q3)

17.00 (14.60–19.00)

14.10 (11.85–18.08)

0.010*†

CRP (mg/L) median (Q1-Q3)

3.23 (3.02–7.07)

3.02 (3.02–3.55)

0.012*†

TSH (mIU/L) median (Q1-Q3)

1.63 (1.10–2.12)

2.35(1.57–3.49)

0.011*†

Hemoglobin (g/dL)

12.59 ± 1.29

12.75 ± 1.14

0.606

Leukocyte (/mL) median (Q1-Q3)

7.86 ± 1.98

6.68 ± 1.23

0.003*

Neutrophil (/mL)

4.44 ± 1.29

3.76 ± 0.89

0.011*

Thrombocyte (/mL)

314.738 ± 87.193

292.214 ± 52.626

0.183

FBG: Fasting blood glucose, HDL-C: High-density lipoprotein cholesterol, LDL-C: Low-density lipoprotein
cholesterol , AST: Aspartate aminotransferase, ALT: Alanin aminotransferase, CRP: C-reactive protein, TSH:
Thyroid-stimulating hormone.
Independent samples t-test; †Mann–Whitney U-test; *Difference is statistically significant

RA, and diameters of RA and RV were significantly higher,
and LVEF, E, and E/A ratio were significantly lower in the
study group as compared to the control group (P < 0.05).
TDE measurements of the groups are shown in Table
4. Among the parameters of atrial electromechanical
conduction PA lateral, PA septum, interatrial EMD, and
intraatrial EMD were found to be prolonged significantly
in the study group (P < 0.001, P = 0.022, P < 0.001, and P <
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0.001, respectively). Additionally, lateral E/Em and septal
E/Em were found to be higher, and septal Em/Am, lateral
Em/Am, and tricuspid Em/Am were found to be lower
in the study group as compared to the control group (P
< 0.05).
Electrocardiographic measurements of the groups
are given in Table 5. Heart rate calculated from ECG was
higher in FMS patients (P = 0.041). Pmin and QTmin was
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Table 3. Standard echocardiographic data of the groups.
Study group
(n = 43)

Control group
(n = 30)

P-value

LVDD (mm)

42.72 ± 2.87

41.60 ± 2.63

0.090

LVSD (mm)

29.05 ± 2.65

28.70 ± 3.61

0.638

IVSd (mm) median (Q1–Q3)

11.00(10.00–12.00)

9.00 (8.00–10.00)

<0.001*†

PWd (mm) median (Q1–Q3)

10.00 (9.00–11.00)

8.00 (7.00–9.00)

<0.001*†

LVEF (%)

64.93 ± 2.45

67.20 ± 1.75

<0.001*

LA, diameter (mm)

29.77 ± 3.83

29.07 ± 2.75

0.393

RA, diameter (mm)

31.44 ± 3.06

29.60 ± 4.61

0.044*

RV (mm) median (Q1–Q3)

28.00(26.00–30.00)

27.00(25.00–29.00)

0.048*†

LA, area (mm2)

14.00 ± 1.21

13.32 ± 1.29

0.024*

RA, area (mm2)

12.61 ± 1.11

11.81 ± 0.96

0.002*

TAPSE (mm)

29.28 ± 2.93

29.17 ± 2.96

0.873

E (cm/s)

75.16 ± 15.21

81.13 ± 10.06

0.047*

A (cm/s) median (Q1–Q3)

67.00(57.00–79.00)

60.00 (57.25–69.25)

0.183†

E/A Ratio

1.15 ± 0.29

1.34 ± 0.24

0.005*

LVDD: Left venricular diastolic diameter, LVSD: Left ventricular systolic diameter, IVSd: Diastolic thickness
of interventricular septum, PWd: Diastolic thickness of posterior wall, LVEF: Left ventricular ejection
fraction, LA: Left atrium, RA: Right atrium, TAPSE: Tricuspid annular plane systolic excursion, E: Early
diastolic velocity, A: Late diastolic velocity.
Independent samples t-test; †Mann–Whitney U-test; *Difference is statistically significant.

significantly lower in the study group (P < 0.001 and P <
0.001 respectively). fQRS morphology was present in 33
(76.7%) patients of study group and in 7 (23.3%) subjects
of the control group. The distribution of fragmentations on
ECGs was inferior (n=20, 60.6%), anterior (n=9, 27.3%),
and lateral (n=4, 12.1%) in the study group (Figures 1
and 2). On ECGs of the control group, the distribution of
fQRS was inferior (n=4, 57.1%) and anterior (n=3, 42.9%).
Pd, QTd, and the ratio of presence of fQRS morphology
were found to be significantly higher in the study group as
compared to the control group (P < 0.001, P < 0.001, and P
< 0.001, respectively).
4. Discussion
Although there are studies evaluating the effects of FMS
on cardiovascular function, there is a paucity of data about
the electrical alterations of conduction that may predict
atrial and/or ventricular arrhythmias in FMS patients
[6,9,12]. To the best of our knowledge, this is the first study
evaluating fQRS morphology and inter- and intraatrial
EMD in addition to ventricular functions in FMS.
Although it has not been clarified yet, central and
peripheral nervous system disorders, hormonal and
immunological abnormalities, genetic susceptibility, and
psychiatric factors are supposed to play a role in etiology
and pathogenesis of FMS [1,22]. Chronic widespread

musculoskeletal pain, tender points, sleep abnormalities,
and exercise intolerance depending on autonomic
dysfunction constitute the clinical picture of FMS [23,24].
Numerous studies have been conducted revealing the
relationship between increased cardiovascular risk and
FMS. In these studies, sedentary life style due to limitation
of movement, increased prevalence of metabolic syndrome,
nondipper type blood pressure pattern associated with
sleep disturbance, high blood pressure levels, high
resting heart rate, and decreased heart rate variability
are reported as the main causative factors for increased
cardiovascular mortality and morbidity [3,4,9,25–28]. In
our study, we investigated cardiovascular risks based on
arterial blood pressure, heart rate, BMI, cholesterol levels,
and CRP. Although systolic blood pressure and heart
rate were within normal limits in all participants, they
were significantly higher in FMS patients as compared
to the control group. Furlan et al. reported that increased
sympathetic and decreased parasympathetic activity
caused an increase in resting blood pressure and heart rate
[23]. We thought that similar results observed in our study
might be clinical reflection of increased sympathetic and
decreased parasympathetic activity in FMS.
One of the reasons for increased cardiovascular risk
in FMS is hypercholesterolemia. It has been shown that
cholesterol level is positively correlated with the severity
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Table 4. Tissue Doppler echocardiographic data of the groups.
Study group
(n = 43)

Control group
(n = 30)

P-value

Lateral Sm (cm/s)

9.60 ± 3.05

10.33 ± 1.97

0.254

Lateral Em (cm/s)

12.00 ± 3.38

15.63 ± 3.49

<0.001*

Lateral Am (cm/s)

10.81 ± 3.27

9.33 ± 2.60

0.043*

PA lateral (ms) median (Q1–Q3)

75.00 (72.00–83.00)

68.00 (66.25–72)

<0.001*†

Septal Sm (cm/s)

8.65 ± 2.10

9.67 ± 1.86

0.037*

Septal Em (cm/s)

10.00 ± 2.39

13.27 ± 2.68

<0.001*

Septal Am (cm/s)

9.77 ± 2.07

9.17 ± 1.64

0.189

PA septum (ms) median (Q1–Q3)

64.00 (59.00–68.00)

61.00 (56.50–62.25)

0.022*†

Tricuspid Sm (cm/s)

13.93 ± 3.54

14.20 ± 2.41

0.718

Tricuspid Em (cm/s)

14.05 ± 3.53

16.33 ± 2.95

0.005*

Tricuspid Am (cm/s)

16.81 ± 3.98

14.07 ± 4.26

0.006*

PA tricuspid (ms) median (Q1–Q3)

55.00 (50.00–61.00)

52.50 (48.75–54.75)

0.070†

Interatrial EMD (ms) median (Q1–Q3)

22.00 (19.00–25.00)

13.00 (12.00–18.00)

<0.001*†

Intraatrial EMD (ms) median (Q1–Q3)

9.00 (8.00–11.00)

6.00 (4.00–7.25)

<0.001*†

Lateral MPI

0.53 ± 0.10

0.54 ± 0.15

0.712

Septal MPI

0.55 ± 0.09

0.55 ± 0.10

0.901

RV MPI

0.59 ± 0.10

0.56 ± 0.11

0.213

LV global MPI

0.55 ± 0.07

0.54 ± 0.10

0.681

Lateral E/Em median (Q1–Q3)

6.36 (4.79–8.44)

5.00 (4.19–6.11)

0.013*†

Septal E/Em median (Q1–Q3)

7.90 (6.58–8.50)

6.18 (5.21–6.86)

0.001*†

Lateral Em/Am

1.21 ± 0.51

1.72 ± 0.63

<0.001*

Septal Em/Am

1.07 ± 0.36

1.52 ± 0.48

<0.001*

Tricuspid Em/Am

0.87 ± 0.24

1.27 ± 0.43

<0.001*

E: Early diastolic velocity of mitral inflow, Sm: Systolic velocity of myocardium, Em: Early diastolic velocity
of myocardium, Am: Late diastolic velocity of myocardium, PA: Time interval from the onset of P wave to the
beginning of the A wave, EMD: Electromechanical delay, interatrial EMD: PA lateral–PA tricuspid, intraatrial EMD:
PA septum–PA tricuspid, RV: Right ventricular, LV: Left ventricular, MPI: Myocardial performance index.
Independent samples t-test; †Mann–Whitney U-test; *Difference is statistically significant

of the disease [29,30]. In compliance with the literature,
fasting blood glucose, total cholesterol, LDL cholesterol,
and triglyceride levels were significantly higher, and HDL-C
cholesterol level was significantly lower in FMS patients. The
mechanism underlying the increase in fasting blood glucose
and cholesterol levels has not been explained clearly. Exercise
intolerance and sedentary life style may have adverse effects
on metabolic parameters of the patients. Additionally,
insulin resistance associated with metabolic syndrome may
contribute to abnormalities in these parameters.
Standard echocardiographic measurements were found
to be within normal limits in both groups. However, IVSd,
PWd, diameters, and areas of left and right atrium were
significantly higher, and E/A ratio was significantly lower
in FMS patients. These subclinical cardiac alterations may
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be explained by increased cardiac afterload developing as
a result of activation of renin angiotensin system triggered
by the increased sympathetic activity and may indicate
the tendency to develop diastolic dysfunction and other
cardiovascular abnormalities.
Previous studies revealed conflicting results about
diastolic function of the left ventricle in FMS [10,31]. In
our study, TDE parameters were used to evaluate diastolic
function. Em/Am obtained from lateral, septal, and tricuspid
annulus was significantly lower, and E/Em obtained from
these three regions was significantly higher in FMS group as
compared to control group. Based on our findings we cannot
claim that FMS causes diastolic dysfunction, but these results
may suggest that there is a tendency to develop diastolic
dysfunction in FMS patients. Diverse results of previous
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Table 5. ECG measurements of the groups.
Study group
(n = 43)

Control group
(n = 30)

P-value

ECG heart rate (beat/m)

75.74 ± 10.28

71.20 ± 8.31

0.041*†

Pmax (ms) median (Q1–Q3)

100.00 (90.00–100.00)

92.50 (90.00–100.00)

0.274†

Pmin (ms) median (Q1–Q3)

60.00 (50.00–70.00)

70.00 (68.75–71.25)

<0.001*†

QTmax (ms) median (Q1–Q3)

380.00 (360.00–390.00)

380.00 (367.50–390.00)

0.360†

QTmin (ms) median (Q1–Q3)

330.00 (310.00–340.00)

350.00 (340.00–360.00)

<0.001*†

Pd median (Q1–Q3)

35.00 (30.00–40.00)

22.50 (20.00–30.00)

<0.001*†

QTd median (Q1–Q3)

50.00 (40.00–60.00)

30.00 (30.00–30.00)

<0.001*†

fQRS, present n (%)

33 (76.7)

7 (23.3)

<0.001*‡

Pmax: Maximum P wave duration, Pmin: Minimum P wave duration, Pd: P dispersion, QTmax: Maximum QT interval,
QTmin: Minimum QT interval, QTd: QT dispersion, fQRS: Fragmented QRS.
Independent samples t-test; †Mann–Whitney U-test; ‡Chi-Square test; *Difference is statistically significant;

studies may be explained by the difference in severity of the
disease and methodological differences. Increased blood
pressure as a result of autonomic dysfunction (increased
sympathetic, decreased parasympathetic activity) may be the
cause of alterations in diastolic parameters of FMS patients.
Atrial fibrillation (AF) is the most common arrhythmia
encountered in clinical practice, and associated with
significant mortality and morbidity due to hemodynamic
impairment and thromboembolic events. Impaired atrial
conduction is an important step in the pathophysiology
of AF. Atrial conduction times can be evaluated with both
invasive (electrophysiological study) and noninvasive (Pd
on ECG and atrial EMD on echocardiography) methods
[12,14,32,33]. Recently, atrial EMD has been extensively used
to predict the development of atrial fibrillation. It has been
shown that impaired atrial conduction is an independent
and strong predictor for development and recurrence of AF,
and TDE is a useful and reliable technique to evaluate atrial
electromechanical properties [34,35]. Prolongation of interor intraatrial EMD and heterogeneous progression of sinus
impulses are electrophysiological features of atrium prone to
AF [32]. It has been shown that atrial EMD is prolonged in
various chronic diseases, but no study has been conducted to
evaluate atrial EMD in FMS [14,15]. In our study, both interand intraatrial EMD was found to be prolonged significantly
in FMS patients. Increased sympathetic activity, and
enlargement of atriums may contribute to prolongation of
atrial EMD which may predict long term risk of development
of atrial fibrillation and associated cardiovascular mortality
and morbidity in FMS patients.
In this study, we also evaluated Pd and QTd, cheap
and easily available electrocardiographic parameters
indicating heterogeneous distribution of signals through
atria and ventricles, respectively. It is known that increased

Pd predicts development of AF while QTd is related
with ventricular arrhythmias [33,36]. Previous studies
investigated Pd and QTd in FMS patients and reported no
significant difference as compared to the control group. In
contrast, we found that both Pd and QTd were significantly
increased in FMS patients as compared to the control
group. Increased Pd in addition to prolonged atrial EMD
in our study supports the suggestion of increased longterm risk of AF development in FMS patients. Moreover,
increased QTd in FMS patients may be related to increased
risk of ventricular arrhythmias and resultant increase in
cardiovascular mortality and morbidity in FMS.
Recently, the presence of fQRS morphology in various
diseases affecting cardiovascular system has been found
to be related with increased mortality and morbidity
[16,17]. fQRS morphology has been thought to develop
as a result of heterogeneous depolarization of ventricular
myocardium caused by ischemia, or fibrosis [37]. In our
study, the presence of fQRS morphology was significantly
more frequent in FMS patients as compared to the control
group. One of the reasons for this finding may be the
significant difference in systolic blood pressure of FMS
patients as compared to control group. Previous studies
have reported that fQRS may be a sign of chronic and
continuous pressure overload, especially due to increased
systolic blood pressure that leads to pathological fibrosis
in the presence or even absence of left ventricular
hypertrophy. Additionally, increased interventricular
septal thickness and left atrial diameter in FMS patients
may also be related to the presence of fQRS in accordance
with previous studies [38,39].
There are some limitations to the present study. The
first limitation is relatively small number of patients with
FMS. Another significant limitation of the study is the lack
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of Holter ECG monitoring to document the relationship
between electrical abnormalities and arrhythmias. Another
limitation is that it is not known whether the patients are
dipper or nondipper. Moreover, detection of myocardial
fibrosis and its relation to electrical abnormalities was not
shown by cardiac magnetic resonance imaging. Finally,
long term follow-up of the patients could not be done to
see the future arrhythmic episodes and their relationship
with prolonged EMD and/or fQRS morphology since it is
a cross-sectional study.
In conclusion, this study revealed subclinical cardiac
electrical alterations such as increased Pd and QTd,
prolonged inter- and intraatrial EMD and increased
frequency of fQRS morphology which may suggest

increased risk of atrial and ventricular arrhythmias in FMS
patients. However, further studies with larger populations
and longer follow-up periods are needed to support our
findings, to detect the prognostic value of these electrical
alterations, to assess their persistency, and to document
their relationship with arrhythmias and long term
cardiovascular complications.
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